Honorary Grant from the Icelandic Technology Development Fund

It was announced today that Oculis was one of two company’s awarded an honorary grant from the Icelandic Technology Development Fund. The Technology Development Fund’s role is to support research and development activities, which aim towards innovation in Icelandic industry. The Technology Development Fund is a competitive fund which issues its calls for proposals twice a year. The grant award is in the amount of ISK 70 million (USD 620 thousand) and is awarded towards the clinical development of Oculis lead candidate, DexNP.